AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30346318 — intervention group
Group type: EXPERIMENTAL
Intervention: Left lateral position
Number of subjects: 21
Study 30346318 — intervention group
Group type: COMPARATOR
Intervention: Lithotomy position
Number of subjects: 21
Study 30346318 — intervention group
Group type: EXPERIMENTAL
Intervention: Both positions
Number of subjects: 21
Study 31185033 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-frail individuals
Number of subjects: 1280
Study 31185033 — intervention group
Group type: EXPERIMENTAL
Intervention: Robust and pre-frail subjects
Number of subjects: 1280
Study 27402427 — intervention group
Group type: EXPERIMENTAL
Intervention: Short (6-mm) dental implants (TG)
Number of subjects: 53
Study 27402427 — intervention group
Group type: COMPARATOR
Intervention: Sinus floor elevation (SFE) with longer (≥10-mm) implants (CG)
Number of subjects: 53
Study 25865751 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/ml of pectin
Number of subjects: 19
Study 25865751 — intervention group
Group type: EXPERIMENTAL
Intervention: 0, 3 and 10 mg/ml of pectin
Number of subjects: 19
Study 25865751 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-methoxy pectin
Number of subjects: 19
Study 25865751 — intervention group
Group type: EXPERIMENTAL
Intervention: High-methoxy pectin
Number of subjects: 19
Study 23761003 — intervention group
Group type: EXPERIMENTAL
Intervention: Rolling walker with a laser beam visual cue
Number of subjects: 22
Study 23761003 — intervention group
Group type: COMPARATOR
Intervention: Without laser beam visual cue
Number of subjects: 22
Study 20030777 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 0
Study 20030777 — intervention group
Group type: COMPARATOR
Intervention: Stretching-control
Number of subjects: 0
Study 19621660 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin 1 g intravenously after induction of anesthesia
Number of subjects: 208
Study 19621660 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic antibiotics
Number of subjects: 208
Study 16724543 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchobos capsules (750 mg)
Number of subjects: 18
Study 16724543 — intervention group
Group type: COMPARATOR
Intervention: Mucopront capsules (750 mg)
Number of subjects: 18
Study 15255911 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological and educational counselling (12-week intervention programme)
Number of subjects: 100
Study 15255911 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study 11525101 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary restriction during FOBT
Number of subjects: 5
Study 11525101 — intervention group
Group type: COMPARATOR
Intervention: No dietary restriction during FOBT
Number of subjects: 5
Study 9257324 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ketamine (60 mg administered six times/d)
Number of subjects: 1
Study 9257324 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 7687093 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine (10 mg)
Number of subjects: 97
Study 7687093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 7687093 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine (any dose)
Number of subjects: 97
Study 3829296 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ranitidine 150 mg with 150 ml water
Number of subjects: 100
Study 3829296 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ranitidine 150 mg with no further fluid
Number of subjects: 100
Study 3829296 — intervention group
Group type: COMPARATOR
Intervention: Placebo with 150 ml water
Number of subjects: 100
Study 3829296 — intervention group
Group type: COMPARATOR
Intervention: Placebo with no further fluid
Number of subjects: 100
Study 3829296 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ranitidine 150 mg (both groups)
Number of subjects: 100
Study 3829296 — intervention group
Group type: COMPARATOR
Intervention: Placebo (both groups)
Number of subjects: 100
Study 3829296 — intervention group
Group type: COMPARATOR
Intervention: Placebo with a sip of water
Number of subjects: 100
Study 3829296 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (both groups)
Number of subjects: 100
Study 31126694 — intervention group
Group type: EXPERIMENTAL
Intervention: Contezolid 1200 mg
Number of subjects: 72
Study 31126694 — intervention group
Group type: EXPERIMENTAL
Intervention: Contezolid 1600 mg
Number of subjects: 72
Study 31126694 — intervention group
Group type: EXPERIMENTAL
Intervention: Contezolid 800 mg
Number of subjects: 72
Study 31126694 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 28079776 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced recovery after surgery protocol
Number of subjects: 100
Study 28079776 — intervention group
Group type: COMPARATOR
Intervention: Routine postoperative care (Control)
Number of subjects: 100
Study 26418678 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructional video on sputum submission
Number of subjects: 200
Study 26418678 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 200
Study 22643213 — intervention group
Group type: EXPERIMENTAL
Intervention: M72/AS01
Number of subjects: 110
Study 22643213 — intervention group
Group type: EXPERIMENTAL
Intervention: M72/AS02
Number of subjects: 110
Study 22643213 — intervention group
Group type: EXPERIMENTAL
Intervention: Mtb72F/AS02
Number of subjects: 110
Study 22643213 — intervention group
Group type: COMPARATOR
Intervention: M72/saline
Number of subjects: 110
Study 22643213 — intervention group
Group type: EXPERIMENTAL
Intervention: AS01
Number of subjects: 110
Study 21779740 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture pulse stimulation therapy alone
Number of subjects: 96
Study 21779740 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage combined with electroacupuncture pulse stimulation therapy
Number of subjects: 96
Study 19220275 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole (0.5 mg)
Number of subjects: 12
Study 19220275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 19220275 — intervention group
Group type: EXPERIMENTAL
Intervention: L-dopa (100 mg)
Number of subjects: 12
Study 19220275 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (2.5 mg)
Number of subjects: 12
Study 16424872 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim
Number of subjects: 522
Study 16424872 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 522
Study 14686887 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomy support
Number of subjects: 0
Study 14686887 — intervention group
Group type: COMPARATOR
Intervention: Rewards
Number of subjects: 0
Study 11535972 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg
Number of subjects: 116
Study 11535972 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil alone
Number of subjects: 116
Study 11535972 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil and L-Arginine
Number of subjects: 116
Study 9597557 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan 100 mg
Number of subjects: 23
Study 9597557 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan 200 mg
Number of subjects: 23
Study 9597557 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan 400 mg
Number of subjects: 23
Study 9597557 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan 800 mg
Number of subjects: 23
Study 7841434 — intervention group
Group type: EXPERIMENTAL
Intervention: Model 2000 disposable‐head Heaf gun
Number of subjects: 1410
Study 7841434 — intervention group
Group type: COMPARATOR
Intervention: fixed‐head Heaf gun
Number of subjects: 1410
Study 2893037 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis with recombinant tissue-type plasminogen activator (rTPA) and immediate percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 367
Study 2893037 — intervention group
Group type: COMPARATOR
Intervention: Non-invasive strategy with thrombolysis (rTPA), heparin, and acetylsalicylic acid without immediate angiography and PTCA
Number of subjects: 367
Study 31169023 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab treatment for choroidal neovascularization due to pathologic myopia
Number of subjects: 200
Study 31169023 — intervention group
Group type: COMPARATOR
Intervention: Income level
Number of subjects: 200
Study 28472901 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management training and standard care
Number of subjects: 202
Study 28472901 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 202
Study 26546548 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAd3-EBO-Z (1 × 10(10) pu, 2·5 × 10(10) pu, 5 × 10(10) pu, 1 × 10(11) pu)
Number of subjects: 111
Study 26546548 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAd3-EBO-Z (1 × 10(11) pu)
Number of subjects: 111
Study 26546548 — intervention group
Group type: EXPERIMENTAL
Intervention: MVA-BN-Filo (2 × 10(8) pfu)
Number of subjects: 111
Study 26546548 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 111
Study 24077657 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive psychotherapy (family‐focused therapy, interpersonal and social rhythm therapy, or cognitive‐behavioral therapy)
Number of subjects: 269
Study 24077657 — intervention group
Group type: COMPARATOR
Intervention: Collaborative care (three‐session comparison treatment)
Number of subjects: 269
Study 24077657 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive psychotherapy
Number of subjects: 269
Study 24077657 — intervention group
Group type: COMPARATOR
Intervention: Collaborative care
Number of subjects: 269
Study 24032193 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior training with head needling retention
Number of subjects: 60
Study 24032193 — intervention group
Group type: COMPARATOR
Intervention: Behavior training after acupuncture treatment
Number of subjects: 60
Study 20452733 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal steroid delivery via iontophoresis or phonophoresis
Number of subjects: 62
Study 20452733 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal steroid delivery via iontophoresis
Number of subjects: 62
Study 20452733 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal steroid delivery via phonophoresis
Number of subjects: 62
Study 20452733 — intervention group
Group type: COMPARATOR
Intervention: Placebo delivery via iontophoresis or phonophoresis
Number of subjects: 62
Study 18984532 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic navigation system (RNS)
Number of subjects: 50
Study 18984532 — intervention group
Group type: COMPARATOR
Intervention: Conventional catheter ablation
Number of subjects: 50
Study 16888420 — intervention group
Group type: EXPERIMENTAL
Intervention: PK‐TURP with 0.9% NaCl irrigation fluid
Number of subjects: 42
Study 16888420 — intervention group
Group type: COMPARATOR
Intervention: TURP with 1.5% glycine irrigation fluid
Number of subjects: 42
Study 12409681 — intervention group
Group type: EXPERIMENTAL
Intervention: Montgomery-Asberg Depression Rating Scale (MADRS)
Number of subjects: 208
Study 12409681 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamilton Depression Rating Scale (HAM-D)
Number of subjects: 208
Study 12409681 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Global Impressions Severity (CGI-S)
Number of subjects: 208
Study 12409681 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Global Impressions Improvement (CGI-I)
Number of subjects: 208
Study 12409681 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study 9891827 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 134
Study 9891827 — intervention group
Group type: COMPARATOR
Intervention: Surgical bypass with implantation of the internal mammary artery
Number of subjects: 134
Study 7972572 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of 35% CO2/65% O2 gas mixture
Number of subjects: 71
Study 7972572 — intervention group
Group type: COMPARATOR
Intervention: Inhalation of air (placebo condition)
Number of subjects: 71
Study 2741903 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone call prenotification plus lottery incentive
Number of subjects: 0
Study 2741903 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcard plus lottery
Number of subjects: 0
Study 2741903 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-page survey with lottery announcement
Number of subjects: 0
Study 2741903 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary incentive of $5.00 contingent on response
Number of subjects: 0
Study 4907811 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (120-320 mg daily)
Number of subjects: 28
Study 4907811 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 31718825 — intervention group
Group type: EXPERIMENTAL
Intervention: Magmaris
Number of subjects: 482
Study 31718825 — intervention group
Group type: COMPARATOR
Intervention: Orsiro
Number of subjects: 482
Study 31105142 — intervention group
Group type: EXPERIMENTAL
Intervention: Mono‐energetic 40‐60 keV images from spectral CCTA using SDCT
Number of subjects: 60
Study 31105142 — intervention group
Group type: COMPARATOR
Intervention: Conventional 120 kVp images
Number of subjects: 60
Study 31105142 — intervention group
Group type: COMPARATOR
Intervention: Conventional 100 kVp images
Number of subjects: 60
Study 31105142 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectral images
Number of subjects: 60
Study 31105142 — intervention group
Group type: EXPERIMENTAL
Intervention: 40‐50 keV images
Number of subjects: 60
Study 29797990 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-anxiety and anti-depression treatment (experimental group)
Number of subjects: 248
Study 29797990 — intervention group
Group type: COMPARATOR
Intervention: No anti-anxiety and anti-depression treatment (control group)
Number of subjects: 248
Study 29797990 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-anxiety and anti-depression treatment (experimental group) for tinnitus
Number of subjects: 248
Study 29797990 — intervention group
Group type: COMPARATOR
Intervention: No anti-anxiety and anti-depression treatment (control group) for tinnitus
Number of subjects: 248
Study 23965700 — intervention group
Group type: EXPERIMENTAL
Intervention: Indwelling urinary catheter
Number of subjects: 200
Study 23965700 — intervention group
Group type: COMPARATOR
Intervention: No indwelling urinary catheter
Number of subjects: 200
Study 21366927 — intervention group
Group type: EXPERIMENTAL
Intervention: Home‐Heart‐Walk intervention
Number of subjects: 166
Study 21366927 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 166
Study 19657075 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual cues indicating grasp of a virtual object during reaching in the force field
Number of subjects: 0
Study 19657075 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual cues indicating object release in the absence of forces
Number of subjects: 0
Study 17303710 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen breathing
Number of subjects: 12
Study 17303710 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (3-g intravenous infusion)
Number of subjects: 12
Study 17303710 — intervention group
Group type: COMPARATOR
Intervention: Room air breathing
Number of subjects: 12
Study 15108068 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis patients
Number of subjects: 14
Study 15108068 — intervention group
Group type: COMPARATOR
Intervention: Renal transplant recipients
Number of subjects: 14
Study 15108068 — intervention group
Group type: COMPARATOR
Intervention: Healthy adults
Number of subjects: 14
Study 15108068 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis
Number of subjects: 14
Study 11936388 — intervention group
Group type: EXPERIMENTAL
Intervention: Local warming (Warm Up, Augustine Medical)
Number of subjects: 421
Study 11936388 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic warming (Bair Hugger, Augustine Medical)
Number of subjects: 421
Study 11936388 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 421
Study 11936388 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed patients (both local and systemic)
Number of subjects: 421
Study 9892907 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-gamma treatment
Number of subjects: 44
Study 9892907 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study 7996318 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma Nail (GN)
Number of subjects: 75
Study 7996318 — intervention group
Group type: COMPARATOR
Intervention: Compression Hip Screw (CHS)
Number of subjects: 75
Study 7996318 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 75
Study 2697199 — intervention group
Group type: EXPERIMENTAL
Intervention: mazindol (2 mg/d)
Number of subjects: 14
Study 2697199 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study 4584640 — intervention group
Group type: EXPERIMENTAL
Intervention: Deglycyrrhizinated liquorice extract (760 mg three times daily)
Number of subjects: 68
Study 4584640 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 31665172 — intervention group
Group type: EXPERIMENTAL
Intervention: MR13A10A
Number of subjects: 149
Study 31665172 — intervention group
Group type: COMPARATOR
Intervention: Original rocuronium
Number of subjects: 149
Study 28405623 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine BCG vaccination at birth
Number of subjects: 149
Study 28405623 — intervention group
Group type: COMPARATOR
Intervention: Delayed BCG vaccination at 8 weeks
Number of subjects: 149
Study 26443438 — intervention group
Group type: EXPERIMENTAL
Intervention: R25 Reciproc preparation
Number of subjects: 341
Study 26443438 — intervention group
Group type: COMPARATOR
Intervention: Conventional hand filing preparation
Number of subjects: 341
Study 24122103 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss group
Number of subjects: 141
Study 24122103 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight gain group
Number of subjects: 141
Study 24122103 — intervention group
Group type: EXPERIMENTAL
Intervention: Unaltered weight group
Number of subjects: 141
Study 21602574 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT plus an ICD
Number of subjects: 1077
Study 21602574 — intervention group
Group type: COMPARATOR
Intervention: ICD alone
Number of subjects: 1077
Study 19491985 — intervention group
Group type: EXPERIMENTAL
Intervention: Trypan blue used during cataract surgery
Number of subjects: 15
Study 19491985 — intervention group
Group type: COMPARATOR
Intervention: Control group (no trypan blue used)
Number of subjects: 15
Study 16293363 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine artery embolization
Number of subjects: 63
Study 16293363 — intervention group
Group type: COMPARATOR
Intervention: Myomectomy
Number of subjects: 63
Study 16825962 — intervention group
Group type: EXPERIMENTAL
Intervention: Reamed intramedullary nailing
Number of subjects: 315
Study 16825962 — intervention group
Group type: COMPARATOR
Intervention: Unreamed intramedullary nailing
Number of subjects: 315
Study 12810768 — intervention group
Group type: EXPERIMENTAL
Intervention: Melissa officinalis extract (60 drops/day)
Number of subjects: 42
Study 12810768 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 10429571 — intervention group
Group type: EXPERIMENTAL
Intervention: Interauricular low‐intensity infrared laser therapy (0.89 nm, 7.6 J/cm)
Number of subjects: 0
Study 10429571 — intervention group
Group type: EXPERIMENTAL
Intervention: Interauricular laser therapy
Number of subjects: 0
Study 8850249 — intervention group
Group type: EXPERIMENTAL
Intervention: UVB irradiation (4 times the minimal erythema dose)
Number of subjects: 19
Study 8850249 — intervention group
Group type: COMPARATOR
Intervention: Control (no UVB irradiation)
Number of subjects: 19
Study 2163421 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 25 mg twice a day
Number of subjects: 125
Study 2163421 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 50 mg once a day
Number of subjects: 125
Study 348407 — intervention group
Group type: EXPERIMENTAL
Intervention: Moisturizing soap bar
Number of subjects: 0
Study 31173451 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive voice response system (G2, n = 64)
Number of subjects: 191
Study 31173451 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabeo-BI app software (G3, n = 64)
Number of subjects: 191
Study 31173451 — intervention group
Group type: COMPARATOR
Intervention: Standard care (G1, n = 63)
Number of subjects: 191
Study 28336107 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched enteral nutrition (EEN)
Number of subjects: 99
Study 28336107 — intervention group
Group type: COMPARATOR
Intervention: Standard enteral nutrition
Number of subjects: 99
Study 25981908 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow oxygen therapy
Number of subjects: 310
Study 25981908 — intervention group
Group type: COMPARATOR
Intervention: Standard oxygen therapy delivered through a face mask
Number of subjects: 310
Study 25981908 — intervention group
Group type: COMPARATOR
Intervention: Noninvasive positive-pressure ventilation
Number of subjects: 310
Study 25981908 — intervention group
Group type: COMPARATOR
Intervention: Noninvasive ventilation
Number of subjects: 310
Study 24180712 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan (12 µg/kg bolus over 15 minutes, followed by 0.2 µg/kg/min infusion for 24 hours)
Number of subjects: 25
Study 24180712 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine (7.5 µg/kg/min infusion for 24 hours)
Number of subjects: 25
Study 24180712 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 25
Study 21593355 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive dietary counseling to modify dietary intake according to current recommendations
Number of subjects: 90
Study 21593355 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dietary counseling)
Number of subjects: 90
Study 19317193 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% CHO (35.1 kJ/kg)
Number of subjects: 0
Study 19317193 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% CHO (70.2 kJ/kg)
Number of subjects: 0
Study 19317193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0